Thrombosis Recurrence and Major Bleeding in Non-Anticoagulated Thrombotic Antiphospholipid Syndrome Patients: Prospective Study from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (Aps Action) Clinical Database and Repository (“Registry”)-Reference-Cited by-同舟云学术

Thrombosis Recurrence and Major Bleeding in Non-Anticoagulated Thrombotic Antiphospholipid Syndrome Patients: Prospective Study from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (Aps Action) Clinical Database and Repository (“Registry”)

Published:2023 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Yelnik Cécile Marie,Erton Zeynep Belce,Drumez Elodie,Cheildze Dachi,Andrade Danieli Castro Oliveira,Clarke Ann E.,Tektonidou Maria,Sciascia Savino,Pardos-Gea Jose,Pengo Vittorio,Ruiz-Irastorza Guillermo,Belmont Michael H.,Lopez Pedrera Chary,Fortin Paul R.,Wahl Denis,Gerosa Maria,Kello Nina,Signorelli Flavio,Atsumi Tatsuya,Ji Lanlan,Cohen Hannah,Branch D. Ware,Nalli Cecilia,Rodriguez-Almaraz Esther,Petri Michelle,Cervera Ricard,Shi Hui,Zuo Yu,Artim-Esen Bahar,Pons-Estel Guillermo,Willis Rohan,Barber Megan,Skieth Leslie,Bertolaccini Maria Laura,Roubey Robert,Erkan Doruk

Publisher

Elsevier BV

Reference26 articles.

1. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome;V Pengo;J Thromb Haemost,2010

2. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome;Ricardo Forastiero;Expert Rev Clin Immunol,2015

3. Predictive value of the Adjusted Global Anti-Phospholipid Syndrome Score on clinical recurrence in APS patients: A longitudinal study;G Barilaro;Rheumatology (Oxford),2022

4. EULAR recommendations for the management of antiphospholipid syndrome in adults;M G Tektonidou;Ann Rheum Dis,2019

5. Prevention and Treatment of Thrombotic Antiphospholipid Syndrome;M Crowther;Antiphospholipid Syndrome: Current Research Highlights and Clinical Insights,2017